Figure 1From: Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae Patient inclusion flowchart - treatment with BLBLI or carbapenem.Back to article page